These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19471)

  • 1. Comparative studies on cyclic AMP binding and protein kinase in cyclic AMP-responsive and -unresponsive Walker 256 mammary carcinomas.
    Cho-Chung YS; Clair T; Yi PN; Parkison C
    J Biol Chem; 1977 Sep; 252(18):6335-41. PubMed ID: 19471
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic AMP-binding proteins and protein kinase during regression of Walker 256 mammary carcinoma.
    Cho-Chung YS; Clair T; Porper R
    J Biol Chem; 1977 Sep; 252(18):6342-8. PubMed ID: 197088
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of nuclear cyclic AMP binding in cyclic AMP-unresponsive Walker 256 mammary carcinoma.
    Cho-Chung YS; Clair T; Huffman P
    J Biol Chem; 1977 Sep; 252(18):6349-55. PubMed ID: 197089
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivatives.
    Cho-Chung YS
    Cancer Res; 1974 Dec; 34(12):3492-6. PubMed ID: 4371966
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic AMP receptor triggers nuclear protein phosphorylation in a hormone-dependent mammary tumor cell-free system.
    Cho-Chung YS; Archibald D; Clair T
    Science; 1979 Sep; 205(4413):1390-2. PubMed ID: 224463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivo.
    Cho-Chung YS
    J Cyclic Nucleotide Res; 1980; 6(3):163-77. PubMed ID: 6255017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide metabolism in Walker carcinoma cells resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1978 Mar; 27(6):947-52. PubMed ID: 207283
    [No Abstract]   [Full Text] [Related]  

  • 8. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
    Bodwin JS; Clair T; Cho-Chung YS
    Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dibutyryl cyclic AMP mimics ovariectomy: nuclear protein phosphorylation in mammary tumor regression.
    Cho-Chung YS; Redler BH
    Science; 1977 Jul; 197(4300):272-5. PubMed ID: 195337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dibutyryl cyclic adenosine 3',5'-monophosphate on in vivo growth of Walker 256 carcinoma: isolation of responsive and unresponsive cell populations.
    Choe-Chung YS; Gullino PM
    J Natl Cancer Inst; 1974 Mar; 52(3):995-6. PubMed ID: 4363699
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of cAMP on neoplastic cell growth and regression. III. Altered cAMP-binding in DBcAMP-unresponsive Walker 256 mammary carcinoma.
    Cho-Chung YS; Clair T
    Biochem Biophys Res Commun; 1975 May; 64(2):768-72. PubMed ID: 167756
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenylate cyclase, cyclic adenosin 3':5'-monophosphate phosphodiesterase, and regression of Walker 256 mammary carcinoma.
    Cho-Chung YS; Newcomer SF
    Cancer Res; 1977 Dec; 37(12):4493-9. PubMed ID: 200352
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenosine 3',5'-cyclic-monophosphate dependent protein kinase and cyclic-AMP-binding in human mammary tumors.
    Eppenberger U; Talmadge K; Küng W; Bechtel E; Preisz J; Huber P; Jungmann RA; Salokangas A
    FEBS Lett; 1977 Aug; 80(1):229-34. PubMed ID: 196926
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine 3',5'-monophosphate (cAMP)-binding proteins and cAMP-dependent protein kinases in bovine adrenal cortical cell plasma membrane.
    Reitherman R; Chen L; Wen S; Harding BW
    Endocrinology; 1981 Jul; 109(1):301-6. PubMed ID: 6263589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic adenosine 3':5'-monophosphate and protein kinase activity in insulin-dependent and -independent mammary tumors.
    Shafie SM; Cho-Chung YS; Gullino PM
    Cancer Res; 1979 Jul; 39(7 Pt 1):2501-4. PubMed ID: 221106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in adenosine 3', 5'-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(16):1831-6. PubMed ID: 9089
    [No Abstract]   [Full Text] [Related]  

  • 17. Increase of cyclic AMP-dependent protein kinase type II as an early event in hormone-dependent mammary tumor regression.
    Cho-Chung YS; Clair T; Zubialde JP
    Biochem Biophys Res Commun; 1978 Dec; 85(3):1150-5. PubMed ID: 216364
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic AMP-dependent protein kinase type I and type II and cyclic AMP binding in human mammary tumors.
    Eppenberger U; Biedermann K; Handschin JC; Fabbro D; Küng W; Huber PR; Roos W
    Adv Cyclic Nucleotide Res; 1980; 12():123-8. PubMed ID: 6250347
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclic AMP and mammary tumor regression.
    Cho-Chung YS
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(4):395-403. PubMed ID: 6254654
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a protein kinase from human seminal plasma.
    Majumder GC
    Biochem Biophys Res Commun; 1978 Apr; 81(4):1217-26. PubMed ID: 27183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.